{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:05:32Z","timestamp":1787069132672,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T00:00:00Z","timestamp":1546387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Key Research and Development Program of Zhejiang Province","award":["2015C03032"],"award-info":[{"award-number":["2015C03032"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81361138021"],"award-info":[{"award-number":["81361138021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81711530049"],"award-info":[{"award-number":["81711530049"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.12.014","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T23:32:55Z","timestamp":1546990375000},"page":"147-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections"],"prefix":"10.1016","volume":"17","author":[{"given":"Tingting","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4845-5904","authenticated-orcid":false,"given":"Yonghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.12.014_bib0005","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1001\/archinte.167.8.834","article-title":"Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota","volume":"167","author":"Uslan","year":"2007","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.jgar.2018.12.014_bib0010","first-page":"129","article-title":"Susceptibility of Escherichia coli strains in hospitals across China: results from the CHINET Antimicrobial Resistance Surveillance Program, 2005-2014","volume":"16","author":"Shen","year":"2016","journal-title":"Chin J Infect Chemother"},{"issue":"2","key":"10.1016\/j.jgar.2018.12.014_bib0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1469-0691.2007.01884.x","article-title":"Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli","volume":"14","author":"Rodr\u00edguez-Ba\u00f1o","year":"2008","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"10.1016\/j.jgar.2018.12.014_bib0020","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/1469-0691.12633","article-title":"Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres","volume":"20","author":"Bilavsky","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.jgar.2018.12.014_bib0025","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1684-1182(10)60048-5","article-title":"Risk factors for bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli","volume":"43","author":"Wu","year":"2010","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jgar.2018.12.014_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkp411","article-title":"Bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome","volume":"65","author":"Gudiol","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.014_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijid.2015.07.010","article-title":"Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study","volume":"39","author":"Denis","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.014_bib0040","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/jac\/dks065","article-title":"Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum b-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis","volume":"67","author":"Rottier","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.014_bib0045","first-page":"11","article-title":"Extended-spectrum beta-lactamases: definition, classification and epidemiology","volume":"17","author":"Ghafourian","year":"2014","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.jgar.2018.12.014_bib0050","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/dkm379","article-title":"Comment on: impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia","volume":"60","author":"Blot","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.014_bib0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","article-title":"Infections with extended-spectrum b-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices","volume":"70","author":"Pitout","year":"2010","journal-title":"Drugs"},{"issue":"12","key":"10.1016\/j.jgar.2018.12.014_bib0060","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/jac\/dks301","article-title":"Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to enterobacteriaceae producing extended-spectrum \u03b2-lactamases: a systematic review and meta-analysis","volume":"67","author":"Vardakas","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.014_bib0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum b-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodriguez-Bano","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2018.12.014_bib0070","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epid"},{"key":"10.1016\/j.jgar.2018.12.014_bib0075","unstructured":"Centers for Disease Control and Prevention. CDC\/NHSN surveillance definitions for specific types of infections. Available at: http:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/17pscNosInfDef_current.pdf. [Accessed 15 January 2014]."},{"key":"10.1016\/j.jgar.2018.12.014_bib0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/00003246-198510000-00009","article-title":"APACHE II: a severity of disease classification system","volume":"13","author":"Knaus","year":"1985","journal-title":"Crit Care Med"},{"issue":"2","key":"10.1016\/j.jgar.2018.12.014_bib0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1444-0903.2001.00029.x","article-title":"Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality","volume":"31","author":"Hill","year":"2001","journal-title":"Int Med J"},{"key":"10.1016\/j.jgar.2018.12.014_bib0090","series-title":"CLSI document M100-S25","article-title":"Performance standards for antimicrobial susceptibility testing, 25th informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"10.1016\/j.jgar.2018.12.014_bib0095","first-page":"1","article-title":"Incidence of extended-spectrum \u03b2-lactamase (esbl)-producing Escherichia coli and Klebsiella infections in the United States: a systematic literature review","author":"Mcdanel","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"7","key":"10.1016\/j.jgar.2018.12.014_bib0100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ajic.2015.02.030","article-title":"Risk factors for bloodstream infection caused by extended-spectrum (-lactamase-producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials including cefepime","volume":"43","author":"Chopra","year":"2015","journal-title":"Am J Infect Control"},{"issue":"3","key":"10.1016\/j.jgar.2018.12.014_bib0105","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000439441","article-title":"Extended-spectrum beta-lactamase-producing bacteria in a urology ward: epidemiology, risk factors and antimicrobial susceptibility patterns","volume":"95","year":"2015","journal-title":"Urol Int"},{"issue":"7","key":"10.1016\/j.jgar.2018.12.014_bib0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3855\/jidc.2788","article-title":"Risk factors for bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli in a Turkish hospital","volume":"7","author":"Kaya","year":"2013","journal-title":"J Infect Dev Ctries"},{"issue":"Suppl. 1","key":"10.1016\/j.jgar.2018.12.014_bib0115","first-page":"S15","article-title":"Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement","volume":"22","author":"Chinese XDR Consensus Working Group","year":"2016","journal-title":"Clin Micro Infect"},{"issue":"3","key":"10.1016\/j.jgar.2018.12.014_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2015.01.001","article-title":"Thirty day all-cause mortality in patients with Escherichia coli bacteraemia in England","volume":"21","author":"Abernethy","year":"2015","journal-title":"Clin Microb Infect"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.014_bib0125","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/649537","article-title":"Community-onset bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: risk factors and prognosis","volume":"50","author":"Rodr\u00edguezba\u00f1o","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.014_bib0130","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5152\/kd.2014.05","article-title":"Risk factors and mortality of bloodstream infections caused by extended-spectrum \u03b2-lactamase-positive Escherichia coli and Klebsiella pneumoniae","volume":"27","author":"Balci","year":"2015","journal-title":"Klimik Dergisi"},{"key":"10.1016\/j.jgar.2018.12.014_bib0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jac\/dkm279","article-title":"Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia","volume":"60","author":"Peralta","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2018.12.014_bib0140","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2147\/IDR.S153246","article-title":"A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality","volume":"11","author":"Xiao","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"9","key":"10.1016\/j.jgar.2018.12.014_bib0145","first-page":"1319","article-title":"Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum \u03b2-lactamase bacteremia","volume":"60","author":"Tamma","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.014_bib0150","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13063-014-0541-9","article-title":"Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli, and Klebsiella spp. (the merino trial): study protocol for a randomised controlled trial","volume":"16","author":"Harris","year":"2015","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.jgar.2018.12.014_bib0155","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jinf.2012.01.008","article-title":"Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae","volume":"64","author":"Kang","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.jgar.2018.12.014_bib0160","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2006.06.015","article-title":"Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"56","author":"Bin","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"24","key":"10.1016\/j.jgar.2018.12.014_bib0165","first-page":"1847","article-title":"Expert consensus on the response strategy of Chinese extended-spectrum \u03b2-lactamase Enterobacteriaceae bacterial infection","volume":"94","author":"Zhou","year":"2014","journal-title":"Natl Med J China"},{"issue":"1","key":"10.1016\/j.jgar.2018.12.014_bib0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant enterobacteriaceae: epidemiology and prevention","volume":"53","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T00:37:51Z","timestamp":1569285471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518302583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":34,"alternative-id":["S2213716518302583"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.014","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Chemotherapy of Infection and Cancer.","name":"copyright","label":"Copyright"}]}}